The Clorox Company

CLX · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.7%

Institutions88.4%

Public / Other

Income Statement

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2012-06-30
Total money the company brought in from its core business during the period, before any costs are subtracted.	$7.10B	$7.09B	$7.39B	$7.11B	$7.34B	$6.72B	$6.21B	$6.12B	$5.97B	$5.47B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$3.89B	$4.04B	$4.48B	$4.56B	$4.14B	$3.66B	$3.49B	$3.45B	$3.30B	$3.16B
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$3.21B	$3.05B	$2.91B	$2.54B	$3.20B	$3.06B	$2.73B	$2.67B	$2.67B	$2.30B
Gross profit as a percentage of revenue.	45.2%	43.0%	39.4%	35.8%	43.6%	45.6%	43.9%	43.7%	44.7%	42.1%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$14.00M	$12.00M	$12.00M	$9.00M	$9.00M	$939.00M	$820.00M	$823.00M	$701.00M	$541.00M
Net income divided by the number of shares outstanding — profit attributable to each share.	$6.00	$2.00	$1.00	$3.75	$5.66	$7.46	$6.42	$6.00	$5.00	$4.14
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$6.00	$2.00	$1.00	$3.73	$5.58	$7.36	$6.32	$6.00	$5.00	$4.09

Balance Sheet

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2012-06-30
Cash and highly liquid short-term investments the company can access almost immediately.	$167.00M	$202.00M	$367.00M	$183.00M	$319.00M	$871.00M	$111.00M	$131.00M	$418.00M	$267.00M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$5.56B	$5.75B	$5.95B	$6.16B	$6.33B	$6.21B	$5.12B	$5.06B	$4.57B	–
All of the company's interest-bearing borrowings, short and long term combined.	$2.49B	$2.48B	$2.53B	$2.71B	$2.78B	$2.78B	$2.68B	$2.48B	$2.19B	$2.72B
Everything the company owes — debt, unpaid bills, and other obligations.	$5.08B	$5.26B	$5.56B	$5.43B	$5.74B	$5.30B	$4.56B	$4.33B	$4.03B	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$321.00M	$328.00M	$220.00M	$556.00M	$411.00M	$908.00M	$559.00M	$726.00M	$542.00M	–

Cash Flow Statement

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2012-06-30
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$981.00M	$695.00M	$1.16B	$786.00M	$1.28B	$1.55B	$992.00M	$974.00M	$868.00M	$620.00M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$220.00M	$212.00M	$228.00M	$251.00M	$331.00M	$254.00M	$206.00M	$194.00M	$231.00M	$192.00M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$761.00M	$483.00M	$930.00M	$535.00M	$945.00M	$1.29B	$786.00M	$780.00M	$637.00M	$428.00M

	You	Peer avg
P/E	19.3	27.3
Revenue Growth	-2.0%	+2.1%
ROE	163.8%	104.9%

The Clorox Company

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison